Catalyst

Slingshot members are tracking this event:

Additional cohort 1 data for Bellerophon's(BLPH) INOpulse delivery device in Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) due to be presented at ATS May 20, 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BLPH Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Inopulse Delivery Device, Pulmonary Arterial Hypertension, Interstitial Lung Disease